富邦基因免疫生技
0089714.33−0.66−4.40%收盤・資料日 2026-11-06
成分股48 項
資料日 2026-11-05；權重合計 100.00%
| 名稱 | 權重 | 前期權重 | 持有 |
|---|---|---|---|
| MODERNA INCMRNA US | 14.13% | 14.36% | 31,951 股 |
| GENMAB A/SGMAB DC | 6.17% | 5.75% | 6,151 股 |
| TWIST BIOSCIENCE CORPTWST US | 4.84% | 5.43% | 21,897 股 |
| Bayer AGBAYN GY | 4.21% | 3.84% | 36,264 股 |
| REGENERON PHARMACEUTICALS INCREGN US | 3.94% | 3.86% | 2,385 股 |
| Takeda Pharmaceutical Co Ltd4502 JP | 3.94% | 3.58% | 49,350 股 |
| EXELIXIS INCEXEL US | 3.62% | 3.64% | 28,762 股 |
| MERCK & CO INCMRK US | 3.38% | 3.28% | 12,549 股 |
| VERTEX PHARMACEUTICALS INCVRTX US | 3.37% | 3.24% | 3,392 股 |
| REVOLUTION MEDICINES INCRVMD US | 3.30% | 3.53% | 10,157 股 |
| ROCHE HOLDING AGROP SE | 3.24% | 3.10% | 3,680 股 |
| INCYTE CORPINCY US | 3.20% | 3.16% | 14,805 股 |
| SANOFISAN FP | 2.93% | 2.76% | 16,822 股 |
| CARIS LIFE SCIENCES INCCAI US | 2.78% | 3.37% | 58,283 股 |
| IPSENIPN FP | 2.73% | 2.53% | 8,310 股 |
| GSK PLCGSK LN | 2.73% | 2.59% | 58,426 股 |
| BIONTECH SEBNTX US | 2.71% | 2.72% | 17,209 股 |
| IMMUNITYBIO INCIBRX US | 2.63% | 2.78% | 179,018 股 |
| IOVANCE BIOTHERAPEUTICS INCIOVA US | 2.62% | 2.79% | 184,629 股 |
| ABCELLERA BIOLOGICS INCABCL US | 2.27% | 2.38% | 111,619 股 |
進出與權重變化2026-11-05 和 2026-11-04 比
新進 0 項
剔除 0 項
權重變化 47 項變化大的在前
| 名稱 | 前期 | 本期 | 變化 |
|---|---|---|---|
| TWIST BIOSCIENCE CORP | 5.43% | 4.84% | −0.60 |
| CARIS LIFE SCIENCES INC | 3.37% | 2.78% | −0.59 |
| GENMAB A/S | 5.75% | 6.17% | +0.42 |
| Takeda Pharmaceutical Co Ltd | 3.58% | 3.94% | +0.37 |
| Bayer AG | 3.84% | 4.21% | +0.36 |
| MODERNA INC | 14.36% | 14.13% | −0.23 |
| REVOLUTION MEDICINES INC | 3.53% | 3.30% | −0.22 |
| IPSEN | 2.53% | 2.73% | +0.20 |
| IOVANCE BIOTHERAPEUTICS INC | 2.79% | 2.62% | −0.18 |
| SANOFI | 2.76% | 2.93% | +0.17 |
持股與權重是投信公布的原值。權重變化含股價漲跌的影響，不等於買賣。